Application 202333
- Type
- ANDA
- Sponsor
- EPIC PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM POLYSTYRENE SULFONATE | SODIUM POLYSTYRENE SULFONATE | POWDER;ORAL, RECTAL | 453.6GM/BOT | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24658-760 | Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | PuraCap Laboratories, LLC | ANDA | Current |
| 24658-760 | Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | PuraCap Laboratories, LLC | ANDA | Current |
| 42806-013 | Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Epic Pharma, LLC | ANDA | Current |
| 42806-013 | Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Epic Pharma, LLC | ANDA | Current |
| 42806-013 | Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | Epic Pharma, LLC | ANDA | Current |